登录  注册

消化病学学术中心

2014 AGA指南:肠易激综合征的药物疗法

The American Gastroenterological Association’s 2014 guideline on pharmacologic management of irritable bowel syndrome.

发布时间:2016-2-1

Irritable bowel syndrome is complex and encompasses several subgroups, including patients with constipation-predominant symptoms and those with diarrhea-predominant symptoms. The recommendations in this guideline apply to patients who meet the diagnostic criteria for IBS. Use of nonpharmaceutical agents (eg, fiber) and other interventions (eg, dietary modification, biofeedback, acupuncture) for treatment of patients with IBS was not covered. For constipation-predominant IBS, linactolide is strongly recommended (high-quality evidence); lubiprostone is conditionally recommended (moderate-quality evidence); and polyethylene glycol (PEG) laxatives are conditionally recommended (low-quality evidence). For diarrhea-predominant IBS, rifaximin and alosteron are conditionally recommended (moderate-quality evidence) and loperamide is conditionally recommended (very low-quality evidence). For IBS in general, tricyclic antidepressants and antispasmodics are conditionally recommended (low-quality evidence). The guideline recommends against use of selective serotonin reuptake inhibitors (SSRIs) for management of IBS (low-quality evidence).

全文地址:
顶一下(0

发表评论

 热门指南  more

学科影响因子排名more

 会议回顾 more

  • “2016 消化中外盛举 Best...

  • AASLD The Liver M...

  • 【专题】2015年美国消化疾病周(...

 热门病例 more

Elsevier中国网站
爱唯医学网
爱思唯尔科技部
NursingChina
柳叶刀中文版
大通医疗决策
医大爱思唯尔
Elsevier医学数据库
CK
Journal Consult
Procedures_CONSULT
ClinicalPharmacologyLogo
3D Interact Anatomy
Mosby’s Nursing Consult
NursingChina
Science Direct